"ALOFT - Aliskiren Observation of Heart Failure Treatment: Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure"

PHASE3CompletedINTERVENTIONAL

Enrollment

280

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

Heart Failure

Interventions

DRUG

aliskiren

Trial Locations (2)

Novartis Pharmaceuticals, East Hanover

Investigative Centers